The Ming Hsieh Institute at USC plays a unique role in funding nanomedicine and targeted immunotherapeutic multi-disciplinary research to improve the lives of patients with cancer. By bringing together faculty from engineering, medicine, the sciences and pharmacy, the institute seeks to cultivate an environment of creativity and collaboration that accelerates translational research at USC.

To this end, the Office of Research will hold a MHI Symposium on Moving Cancer Research Into Clinical Trials on Friday, October 19, 2018 from 8:00 am to 2:00 pm. The institute’s founder and USC alumnus Ming Hsieh will be in attendance, as well as a special keynote speaker. An invitation with a link to RSVP for this event will go out via email to prospective attendees.